Evidence map›Paper›PMID 34521839›Full record

ArticleNature communications2021

Large scale enzyme based xenobiotic identification for exposomics.

Ken H Liu, Choon M Lee, Grant Singer, Preeti Bais, Francisco Castellanos, Michael H Woodworth, Thomas R Ziegler, Colleen S Kraft, Gary W Miller, Shuzhao Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Testing Strategies for Metabolite-Mediated Neurotoxicity.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. AI-driven discovery of blood xenobiotic biomarkers in neovascular age-related macular degeneration using iterative random forests.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Exploring Single-Cell Exposomics by Mass Spectrometry.Environmental science & technology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ken H LiuClinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-9736-5828
Choon M LeeDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.
Grant SingerDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.
Preeti BaisThe Jackson Laboratory for Genomic Medicine, Atlanta, Connecticut, USA.
Francisco CastellanosThe Jackson Laboratory for Genomic Medicine, Atlanta, Connecticut, USA.
Michael H WoodworthDivision of Infectious Disease, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-6181-4599
Thomas R ZieglerDivision of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Colleen S KraftDivision of Infectious Disease, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Gary W MillerDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York, USA.ORCID 0000-0001-8984-1284
Shuzhao LiThe Jackson Laboratory for Genomic Medicine, Atlanta, Connecticut, USA.
Young-Mi GoClinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, Georgia, USA.
Edward T MorganDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA. etmorga@emory.edu.ORCID 0000-0003-4273-2261
Dean P JonesClinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, Georgia, USA. dpjones@emory.edu.ORCID 0000-0002-2090-0677
Emory University · USJackson Laboratory · USColumbia University · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Pilot Project ProgramP30ES019776 · NIEHS · EMORY UNIVERSITY · PI Carmen Joseph Marsit · 2013 to 2026
$22.6M
Epidemiological Integration of Genetic Variants and Metabolomics Profiles in Washington Heights Columbia Aging ProjectRF1AG066107 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P, MILLER, GARY W · 2020 to 2022
$11.4M
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genomeRC2DK118619 · NIDDK · MAYO CLINIC ROCHESTER · PI LAZARIDIS, KONSTANTINOS N · 2018 to 2022
$7.8M
Vesicular Modulation of Dopamine Neuron ToxicityR01ES023839 · NIEHS · EMORY UNIVERSITY · PI MILLER, GARY W · 2015 to 2025
$5.0M
U2C Experimental CoreU2CES030163 · NIEHS · EMORY UNIVERSITY · PI MORGAN, EDWARD THOMAS · 2018 to 2021
$3.6M
Temporal dynamics of MDRO eradication after FMTK23AI144036 · NIAID · EMORY UNIVERSITY · PI WOODWORTH, MICHAEL HOLMES · 2019 to 2023
$957k
Orbitrap Elite/H-ESI BundleS10OD018006 · OD · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 2014 to 2014
$600k
NCATS NIH HHS UL1 TR002378NIAID NIH HHS K23 AI144036NIAID NIH HHS UM1 AI104681NIA NIH HHS RF1 AG066107NIDDK NIH HHS RC2 DK118619NIEHS NIH HHS P30 ES019776NIEHS NIH HHS R01 ES023839NIEHS NIH HHS U2C ES030163NIH HHS S10 OD018006
6 · The paper itself

Abstract

Advances in genomics have revealed many of the genetic underpinnings of human disease, but exposomics methods are currently inadequate to obtain a similar level of understanding of environmental contributions to human disease. Exposomics methods are limited by low abundance of xenobiotic metabolites and lack of authentic standards, which precludes identification using solely mass spectrometry-based criteria. Here, we develop and validate a method for enzymatic generation of xenobiotic metabolites for use with high-resolution mass spectrometry (HRMS) for chemical identification. Generated xenobiotic metabolites were used to confirm identities of respective metabolites in mice and human samples based upon accurate mass, retention time and co-occurrence with related xenobiotic metabolites. The results establish a generally applicable enzyme-based identification (EBI) for mass spectrometry identification of xenobiotic metabolites and could complement existing criteria for chemical identification.

Indexed as

AnimalsCytochrome P-450 Enzyme SystemGene ExpressionHumansIsoenzymesIsotope LabelingLiverMass SpectrometryMetabolic Detoxication, Phase IMetabolic Detoxication, Phase IIMiceMicrosomes, LiverXenobioticsCytochrome P-450 Enzyme SystemIsoenzymesXenobiotics

Identifiers

PMID34521839
PMCPMC8440538
OpenAlexW3122419300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.